| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/17/2008 | US20080091024 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles |
| 04/17/2008 | US20080091023 Processes for optical resolution of 1-phenyl-1,2,3,4-tetrahydroisoquinoline |
| 04/17/2008 | US20080091010 Induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; antiviral and antitumor agents |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090891 Administering calcium channel modulators 2-(alkyl or (hetero)arylalkylthio)-imidazoles and S-oxides thereof; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 04/17/2008 | US20080090880 3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators |
| 04/17/2008 | US20080090877 Sulfone impurity can be removed using amine salts of 2-[(4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole when manufacturing the drug pariprazole |
| 04/17/2008 | US20080090872 AMPA and NMDA receptor modulators; depression, epilepsy, schizophrenia, Alzheimer's, disease, learning and memory disorders, and mild cognitive impairment; 5,1',5'-trimethyl-2'-phenyl-1',2'-dihydro-2H-[3,4']bipyrazolyl-3'-one for example |
| 04/17/2008 | US20080090871 Cannabimimetic indole derivatives |
| 04/17/2008 | US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide |
| 04/17/2008 | US20080090847 Heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090836 Pyrazole Compounds Useful In The Treatment Of Inflammation |
| 04/17/2008 | US20080090834 Selective azole pde10a inhibitor compounds |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
| 04/17/2008 | US20080090828 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide |
| 04/17/2008 | US20080090827 Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| 04/17/2008 | US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors |
| 04/17/2008 | US20080090821 Improved solubility, lower tendency to bind to plasma proteins and greater activity especially in serum-based assay systems; remodeling of heart after myocardial infarction; atherosclerosis; 2-[4-(4-Fluorophenoxy)benzenesulfonyl]-6-(2-piperidin-1-ylethoxy)-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid |
| 04/17/2008 | US20080090816 Anti-infective biaryl compounds |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090813 4-(3-hydroxy-1-propyl)-6-(3-trifluoromethylphenyl)-pyrimidine-2-carbonitrile; cysteine proteases (cathepsin K and S) inhibitor; antiinflammatory and analgesic agent; rheumatoid arthritis, multiple sclerosis, chronic and neuropathic pain |
| 04/17/2008 | US20080090809 Pyrazole compounds |
| 04/17/2008 | US20080090807 Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090802 2-[2-(3-Chlorophenyl)-4-oxo-6-perhydro-1,4-diazepin-1-yl-4H-quinazolin-3-yl]-N-isopropylacetamide; hypothalamo-pituitary-adrenal (HPA) axis stress relieving agent; adrenocorticotropic hormone (ACTH)/ glucocorticoid antagonist; psychological and bipolar disorders, schizophrenia, psychosis, hyperactivity |
| 04/17/2008 | US20080090800 Mandelic acid derivatives and their use as thrombin inhibitors |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090796 Useful in the treatment of neurological and psychiatric disorders associated with glutamatergic neurotransmission dysfunction and diseases; schizophrenia; 2,4-dichloro-N-{[4-(cyclopropylmethyl)-1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl]methyl}benzamide |
| 04/17/2008 | US20080090794 Potassium Channel Inhibitors |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | US20080090174 Novel Oxonol Dye Compounds and Optical Information Recording Medium |
| 04/17/2008 | CA2675511A1 N-aryl pyrazole compounds for use against diabetes |
| 04/17/2008 | CA2666396A1 Physiologically acceptable salts of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester |
| 04/17/2008 | CA2666275A1 Cyclopropyl-piperazine compounds as calcium channel blockers |
| 04/17/2008 | CA2666177A1 Acylaminoimidazoles and acylaminothiazoles |
| 04/17/2008 | CA2666084A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | CA2665629A1 Heterocyclic derived metalloprotease inhibitors |
| 04/17/2008 | CA2664631A1 Quinoline derivatives for modulating dna methylation |
| 04/17/2008 | CA2664579A1 2-aminocarbonyl-pyridine derivatives |
| 04/17/2008 | CA2659923A1 Substituted pyrazinone derivatives for use as a medicine |
| 04/16/2008 | EP1911756A2 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 04/16/2008 | EP1911755A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911753A1 Spiro-cyclic compound |
| 04/16/2008 | EP1911747A1 Sulfonamide substituted pyrazoline compounds, their preparation and use as CB1 modulators |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911350A1 Amidine compound and herbicide |
| 04/16/2008 | EP1910385A1 Benzothiazoles and thiazolopyridines as sirtuin modulators |
| 04/16/2008 | EP1910384A1 Imidazo [2,1-b]thiayole derivatives as sirtuin modulating compounds |
| 04/16/2008 | EP1910378A1 Hepatitis c inhibitor peptide analogs |
| 04/16/2008 | EP1910362A1 Imidazopyridine derivatives as sirtuin modulating agents |
| 04/16/2008 | EP1910342A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 04/16/2008 | EP1910340A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 04/16/2008 | EP1910338A2 Heterotetracyclic compounds as tpo mimetics |
| 04/16/2008 | EP1910337A2 Heteroaryl derivatives for treating viruses |
| 04/16/2008 | EP1910336A1 Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 04/16/2008 | EP1910335A1 N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and use thereof |
| 04/16/2008 | EP1910334A2 Compounds and methods for treatment of amyloid-beta-peptide related disorders |
| 04/16/2008 | EP1910333A1 Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 04/16/2008 | EP1910332A2 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910331A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS |
| 04/16/2008 | EP1910330A1 Heterocyclylamide-substituted thiazoles, pyrroles and thiophenes |
| 04/16/2008 | EP1910329A1 4-chromenonyl-1,4-dihydropyridines and their use |
| 04/16/2008 | EP1910321A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 04/16/2008 | EP1910315A2 Benzodiazepine derivatives, their preparation and the therapeutic use thereof |
| 04/16/2008 | EP1910314A1 Benzimidazole derivatives for treatment of inflammatory diseases |
| 04/16/2008 | EP1910308A1 Imidazole based lxr modulators |
| 04/16/2008 | EP1910307A1 Pyrazole based lxr modulators |
| 04/16/2008 | EP1910302A1 Carbonyl substituted pyrazoline compounds, their preparation and use as cb1 receptor modulators |
| 04/16/2008 | EP1910298A2 Phenylglycinamide and pyridylglycinamide derivatives useful as anticoagulants |
| 04/16/2008 | EP1910293A1 Isotopically substituted proton pump inhibitors |
| 04/16/2008 | EP1910290A2 Gpcr agonists |
| 04/16/2008 | EP1910272A1 Renin inhibitors |
| 04/16/2008 | EP1909910A1 Benzimidazole derivatives as sirtuin modulators |
| 04/16/2008 | EP1909791A1 G-protein coupled receptor agonists |
| 04/16/2008 | EP1909572A2 Potassium channel inhibitors |
| 04/16/2008 | EP1578727B1 Tetrahydroquinoline derivatives and their use as fsh receptor modulators |
| 04/16/2008 | EP1309585B1 Novel indole derivatives and their use as medicaments |
| 04/16/2008 | CN101163696A Histone deacetylase inhibitors |
| 04/16/2008 | CN101163695A Piperidinyl piperazine derivatives useful as inhibitors of chemokine receptors |
| 04/16/2008 | CN101163694A Imidaz0l0-5-yl-2-anil0-pyrimidines as agents for the inhibition of cell proliferation |
| 04/16/2008 | CN101163693A Antibacterial piperidine derivatives |
| 04/16/2008 | CN101163692A Heterocyclic substituted piperazines with cxcr3 antagonist activity |
| 04/16/2008 | CN101163691A 1,3-diaryl substituted ureas as modulators of kinase activity |
| 04/16/2008 | CN101163685A Pharmaceutically active diazepanes |
| 04/16/2008 | CN101163684A Quinazoline derivative having tyrosine kinase inhibitory activity |
| 04/16/2008 | CN101163678A 吡啶基甲基砜衍生物 Pyridyl methyl sulfone derivative |
| 04/16/2008 | CN101163478A Compounds for inflammation and immune-related uses |
| 04/16/2008 | CN101163477A Multimediator dopamine transport inhibitors, and uses related thereto |
| 04/16/2008 | CN101163472A Vla-4 antagonists |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381438C New pyrrolidine and thiazolidine compounds, process for their preparation and pharmaceutical compositions containing them |
| 04/16/2008 | CN100381428C Quinazolone and quinazolone compound and application thereof |
| 04/16/2008 | CN100381425C 6-amino-1H-indazole and its pharmaceutical compositions as phosphodiesterase 4 inhibitors, and use thereof |
| 04/16/2008 | CN100381423C Novel piperidine derivatives as modulators of chemokine receptor CCR5 |